{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChangePercent": -0.32859263, "regularMarketPrice": 0.091, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.09, "sharesOutstanding": 201375008, "bookValue": 0.101, "fiftyDayAverage": 0.107436, "fiftyDayAverageChange": -0.016436003, "fiftyDayAverageChangePercent": -0.15298413, "twoHundredDayAverage": 0.178815, "twoHundredDayAverageChange": -0.08781501, "twoHundredDayAverageChangePercent": -0.49109417, "marketCap": 20828262, "priceToBook": 0.90099007, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "exchange": "STU", "shortName": "Synairgen PLC", "longName": "Synairgen plc", "messageBoardId": "finmb_20361040", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "firstTradeDateMilliseconds": 1503900000000, "priceHint": 4, "regularMarketChange": -0.00030000508, "regularMarketTime": 1683871719, "regularMarketDayHigh": 0.091, "regularMarketDayRange": "0.091 - 0.091", "regularMarketDayLow": 0.091, "regularMarketVolume": 0, "regularMarketPreviousClose": 0.0913, "bid": 0.1024, "ask": 0.1226, "bidSize": 0, "askSize": 0, "fullExchangeName": "Stuttgart", "financialCurrency": "GBP", "regularMarketOpen": 0.091, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.031099997, "fiftyTwoWeekLowChangePercent": 0.5191986, "fiftyTwoWeekRange": "0.0599 - 0.412", "fiftyTwoWeekHighChange": -0.321, "fiftyTwoWeekHighChangePercent": -0.7791262, "fiftyTwoWeekLow": 0.0599, "fiftyTwoWeekHigh": 0.412, "trailingAnnualDividendRate": 0.0, "symbol": "OMY.SG"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Mailpoint 810", "address2": "Level F, South Block Southampton General Hospital Tremona Road", "city": "Southampton", "zip": "SO16 6YD", "country": "United Kingdom", "phone": "44 23 8051 2800", "fax": "44 23 8051 2800", "website": "https://www.synairgen.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-\u00df), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-\u00df that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease. The company has a licensing and collaboration agreement with Pharmaxis Ltd. to develop a LOXL2 inhibitor. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard  Marsden", "age": 54, "title": "CEO, MD & Exec. Director", "yearBorn": 1968, "fiscalYear": 2021, "totalPay": {"raw": 1290275, "fmt": "1.29M", "longFmt": "1,290,275"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 2302129, "fmt": "2.3M", "longFmt": "2,302,129"}}, {"maxAge": 1, "name": "Prof. Stephen T. Holgate CBE, M.D.", "age": 74, "title": "Co-Founder, Non-Exec. Director & Member of Scientific Advisory Board", "yearBorn": 1948, "fiscalYear": 2021, "totalPay": {"raw": 37875, "fmt": "37.88k", "longFmt": "37,875"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John  Ward", "age": 60, "title": "CFO & Exec. Director", "yearBorn": 1962, "fiscalYear": 2021, "totalPay": {"raw": 1119837, "fmt": "1.12M", "longFmt": "1,119,837"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1790545, "fmt": "1.79M", "longFmt": "1,790,545"}}, {"maxAge": 1, "name": "Dr. Phillip David Monk", "age": 53, "title": "Chairman of Scientific Advisory Board, Chief Scientific Officer & Exec. Director", "yearBorn": 1969, "fiscalYear": 2021, "totalPay": {"raw": 956975, "fmt": "956.98k", "longFmt": "956,975"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1662650, "fmt": "1.66M", "longFmt": "1,662,650"}}, {"maxAge": 1, "name": "Prof. Donna  Davies", "title": "Co-Founder & Member of Scientific Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Ratko  Djukanovic", "title": "Co-Founder & Member of Scientific Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Brooke S Clarke", "title": "Sr. VP & Head of Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Gareth E. Walters Ph.D.", "age": 63, "title": "Chief Regulatory Officer", "yearBorn": 1959, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jody  Brookes", "title": "Sr. VP & Head of Clinical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Richard  Hennings", "age": 52, "title": "Chief Commercial Officer", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}